Concepedia

Shelby A. Labe

SA

4

Publications

127

Citations

4

H-Index

2017

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Dana-Farber Brigham Cancer Center

Brigham and Women's Hospital

Harvard University

Shelby A. Labe is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2017–2018

4

Publications

4

Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer

David D. Yang, Brandon A. Mahal, Vinayak Muralidhar et al. · European Urology Focus · 2017 · 54 citations

, , +4

Receipt of definitive therapy in elderly patients with unfavorable‐risk prostate cancer

David D. Yang, Brandon A. Mahal, Vinayak Muralidhar et al. · Cancer · 2017 · 28 citations · Full text

Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance

David D. Yang, Brandon A. Mahal, Vinayak Muralidhar et al. · Clinical Genitourinary Cancer · 2017 · 24 citations

, , +8

NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair

Peter Deraska, Colin O’Leary, Hunter D. Reavis et al. · Cell Death Discovery · 2018 · 21 citations · Full text

, , +19

Rows per page

1–4 of 4